612 results on '"Szczech, Lynda A."'
Search Results
2. Roxadustat for CKD-related Anemia in Non-dialysis Patients
3. Disease State: Kidney Disease
4. O9 Results from a planned interim analysis of a randomized, double-blind, active-controlled trial evaluating the effects of obeticholic acid and bezafibrate on serum biomarkers in primary biliary cholangitis
5. Tenofovir Use and Urinary Biomarkers Among HIV-Infected Women in the Women's Interagency HIV Study (WIHS)
6. Results from a planned interim analysis of a randomized, double-blind, active-controlled trial evaluating the effects of obeticholic acid and bezafibrate on serum biomarkers in primary biliary cholangitis
7. Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study
8. Glomerular Diseases Associated with HIV, Hepatitis B, and Hepatitis C Infections
9. An Equation Based on Fuzzy Mathematics to Assess the Timing of Haemodialysis Initiation
10. Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD
11. Disease State: Kidney Disease
12. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD
13. Patient and Caregiver Knowledge and Utilization of Partial Versus Radical Nephrectomy: Results of a National Kidney Foundation Survey to Assess Educational Needs of Kidney Cancer Patients and Caregivers
14. What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: How Hypoxia‐Inducible Factor‐Prolyl Hydroxylase Inhibitors May Change Iron Management in End‐Stage Renal Disease
15. Retraction notice to “Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis.” Kidney Int Rep. 2021;6:613–623
16. Proteinuria, Creatinine Clearance, and Immune Activation in Antiretroviral-Naive HIV-Infected Subjects
17. Kidney Disease in Patients with HIV Infection and AIDS
18. Tenofovir Nephrotoxicity: Focusing Research Questions and Putting Them into Clinical Context
19. Investigators’ Experience With Expedited Safety Reports Prior to the FDA’s Final IND Safety Reporting Rule
20. Clinical Outcomes and Costs Due to Staphylococcus aureus Bacteremia Among Patients Receiving Long‐Term Hemodialysis
21. Costs and Outcomes Among Hemodialysis‐Dependent Patients With Methicillin‐Resistant or Methicillin‐Susceptible Staphylococcus aureus Bacteremia
22. Management of HIV-Infected Patients With ESRD
23. Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non–Dialysis-Dependent CKD
24. RETRACTED: Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis
25. Association of Blood Pressure Increases During Hemodialysis With 2-Year Mortality in Incident Hemodialysis Patients: A Secondary Analysis of the Dialysis Morbidity and Mortality Wave 2 Study
26. Hepatitis C Seropositivity and Kidney Function Decline Among Women With HIV: Data From the Women's Interagency HIV Study
27. Uses and Interpretation of Iron Studies in Patients on Chronic Dialysis
28. FC 071ENHANCED DEGRADATION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE (HMGCR) MAY CONTRIBUTE TO THE LOWERING OF LDL CHOLESTEROL SEEN WITH ROXADUSTAT IN CHRONIC KIDNEY DISEASE PATIENTS WITH ANEMIA
29. Cockcroft-Gault Versus Modification of Diet in Renal Disease: Importance of Glomerular Filtration Rate Formula for Classification of Chronic Kidney Disease in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
30. Acute Kidney Injury in HIV-Infected Patients
31. The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial
32. Assessing the Economic Attractiveness of Coronary Artery Revascularization in Chronic Kidney Disease Patients
33. Roxadustat for anemia in patients with end-stage renal disease incident to dialysis
34. OS-046 - Results from a planned interim analysis of a randomized, double-blind, active-controlled trial evaluating the effects of obeticholic acid and bezafibrate on serum biomarkers in primary biliary cholangitis
35. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible staphylococcus aureus bacteremia
36. Glomerular Diseases Associated with HIV, Hepatitis B, and Hepatitis C Infections
37. Relationship Between Interdialytic Weight Gain and Blood Pressure Among Prevalent Hemodialysis Patients
38. Immunosuppression, Hepatitis C infection, and acute renal failure in HIV-infected patients
39. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV medicine association of the Infectious Diseases Society of America
40. Renal complications of HIV infection
41. Contributors
42. Management of the patient with progressive renal failure
43. Contributors
44. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy
45. Anticogulation in acute cardiac care in patients with chronic kidney disease
46. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women
47. RESTLESS LEGS SYNDROME REPORTED BY INCIDENT HAEMODIALYSIS PATIENTS: IS TREATMENT TIME OF DAY RELEVANT?
48. The Uncertain Significance of Anti–Glomerular Basement Membrane Antibody Among HIV-Infected Persons With Kidney Disease
49. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. (Original Contribution)
50. Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.